Investor profile

Fund F EuVECA GmbH & Co KG CD3 IV (Centre for Drug Design and

Fund F GmbH KU Leuven Research & · Austria

Investment focus

Start with the fit.

Fund F EuVECA (CD3 IV) is a social-impact venture fund managed by Fund F in Austria, linked to the Centre for Drug Design and Discovery (CD3) at KU Leuven. It invests in early-stage life-science and drug-development projects, with a social impact and innovation focus.

Reported EIF strategy: Social impact Investing & Social Innovation

AI Connector · MCP

Bring EUACC into your AI.

Choose your AI and follow the walkthrough. Your free EUACC account connects the two.

Illustrated walkthrough

Add EUACC to Claude

In Claude, open Customize, then Connectors.
Click + Add, then Add custom connector.
Name it EUACC, paste the link and click Continue.
Review the detected authentication settings and click Continue. Choose Sign in now, then Register automatically under OAuth client.
Click Add, then sign in with your free EUACC account and approve access.

Connector URLhttps://www.euacc.ai/api/mcp

Works on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.

On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.

Once connected, try this

Use EUACC to explore “Fund f euveca gmbh co kg cd3 iv centre for drug design and” (https://www.euacc.ai/investors/fund-f-euveca-gmbh-co-kg-cd3-iv-centre-for-drug-design-and). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.

Your side of the introduction

Give investors a profile worth opening.

List your startup →